Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Anika Therapeutics | ANIK | 8. jan 2025 | 15.94 | +1.53 |
Anixa Biosciences | ANIX | 8. jan 2025 | 2.25 | -4.66 |
Annaly Capital Management | NLY | 8. jan 2025 | 18.51 | -0.70 |
Annaly Capital Management F Pref | NLY-F | 8. jan 2025 | 25.68 | -0.04 |
Annaly Capital Management G Pref | NLY-G | 8. jan 2025 | 25.41 | +0.08 |
Annaly Capital Management I Pref | NLY-I | 8. jan 2025 | 25.43 | -0.04 |
Annexon | ANNX | 8. jan 2025 | 4.84 | -4.16 |
Annovis Bio | ANVS | 8. jan 2025 | 5.16 | +2.18 |
ANSYS | ANSS | 8. jan 2025 | 343.47 | +2.27 |
Antelope Enterprise | AEHL | 8. jan 2025 | 0.18 | -21.72 |
Anteris Technologies Global | AVR | 8. jan 2025 | 5.63 | 0.00 |
Anterix | ATEX | 8. jan 2025 | 29.74 | +1.40 |
Antero Midstream | AM | 8. jan 2025 | 15.64 | +1.10 |
Antero Resources | AR | 8. jan 2025 | 37.86 | +3.22 |
Anywhere Real Estate | HOUS | 8. jan 2025 | 3.11 | -3.12 |
Aon | AON | 8. jan 2025 | 352.45 | +1.15 |
APA | APA | 8. jan 2025 | 23.68 | +0.08 |
Apartment Investment and Management | AIV | 8. jan 2025 | 8.61 | -0.46 |
Apellis Pharmaceuticals | APLS | 8. jan 2025 | 33.00 | -4.71 |
APi Group | APG | 8. jan 2025 | 36.36 | -1.70 |
Apogee Enterprises | APOG | 8. jan 2025 | 52.52 | -8.82 |
Apogee Therapeutics | APGE | 8. jan 2025 | 49.21 | -0.73 |
Apollo Commercial Real Estate Finance | ARI | 8. jan 2025 | 8.78 | -0.79 |
Apollo Global Management | APO | 8. jan 2025 | 161.98 | -0.29 |
Apollomics | APLM | 8. jan 2025 | 10.34 | -3.27 |
AppFolio A | APPF | 8. jan 2025 | 253.59 | +1.61 |
Appian A | APPN | 8. jan 2025 | 34.74 | -1.05 |
Apple | AAPL | 8. jan 2025 | 242.70 | +0.20 |
Apple Hospitality REIT | APLE | 8. jan 2025 | 14.55 | -0.48 |
Applied Digital | APLD | 8. jan 2025 | 8.71 | -7.59 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.